Study amounts are not personal directions
CJC-1295 dosage: amounts used in small studies
This is an unapproved, lab-made piece of protein. The page tells you what researchers gave people and why that does not set a safe amount.
The chronology
The chronology
- What CJC-1295 dosage appeared in studies
- Where CJC-1295 studies gave the shot
- Does any study set a safe CJC-1295 amount for me
- Does any study set a safe CJC-1295 DAC amount
- Is there a safe CJC-1295 and ipamorelin amount
- Why CJC-1295 studies used shots instead of pills
- What the small human studies can support
- Why the two forms can't share one plan
What CJC-1295 dosage appeared in studies
No CJC-1295 dosage has been approved for people. Human studies used 30, 60, or 90 micrograms, or millionths of a gram, for each kilo of body weight [1][3]. The amount came in one shot into the fat under the skin. Researchers watched the compound, growth hormone, and a liver-made growth reading in your blood; those figures don't prove an amount is safe for you.
A mouse study used 2 micrograms at 24-, 48-, or 72-hour gaps [4]. The mice were bred without the body message that normally starts growth-hormone release. Results from such mice can't set a human amount. Their bodies began from a very different place.
Online posts often list 100 to 300 micrograms for the short form or for a CJC-1295/ipamorelin pair. Ipamorelin is another compound that can prompt growth hormone release. Those figures didn't come from trials in people. A posted number is not a personal plan.
Where CJC-1295 studies gave the shot
Human and animal studies gave CJC-1295 by a shot in the fatty layer beneath the skin [1][3][4]. Early work on the natural peptide used a shot into a vein [12]. The small protein would come apart in your stomach before it could work, so the studies didn't use a pill.
These facts only describe the research; they aren't personal directions for you. The studies had blood checks and trained staff, unlike use at home.
Does any study set a safe CJC-1295 amount for me
No human amount of CJC-1295 is approved. In the studies, a shot beneath the skin held 30, 60, or 90 micrograms for each kilo of body weight [1][3]. A microgram is one millionth of a gram. Online amounts didn't come from controlled trials, and no study figure sets a safe amount for you.
Does any study set a safe CJC-1295 DAC amount
The DAC form keeps growth hormone and IGF-1, a growth reading made mainly by the liver, high for days after one amount [1]. In human studies, a shot beneath the skin held 30 to 90 micrograms per kilo [1][3]. A microgram is one millionth of a gram. Those study amounts are not proved safe for you, and no human amount is approved.
Is there a safe CJC-1295 and ipamorelin amount
No approved human amount exists for CJC-1295, ipamorelin, or the pair. Ipamorelin is another compound that can prompt growth hormone release. Studies of similar compounds found a larger growth-hormone rise from the two messages together. Human studies haven't settled how much of this exact pair is safe or useful.
Why CJC-1295 studies used shots instead of pills
Your stomach would destroy this small protein before it could work, which is why researchers used shots rather than pills. For lab work, the dried peptide was mixed with germ-free water and kept cold. The long form also used a bond with a protein that carries substances through your blood.
These facts explain only how the research was done; they don't tell you how to mix, store, or take the compound. No agency has approved the compound for people, so the lab step isn't a personal direction.
What the small human studies can support
The human record is small. In healthy adults, short studies watched growth hormone and IGF-1, a liver-made reading. The CJC-1295 DAC form had a 5.8-to-8.1-day stay [1][3]. The work focused on blood tests.
Another study found that a fragment from an immune protein or the main carrying protein in your blood changed with the liver-made reading [5]. That showed another blood-test change; it didn't show that people became stronger, leaner, or healthier. The finding also does not help you choose an amount.
No large trial has proved better health in healthy adults, and no long-term safety trial has been done. A Phase 2 study, an early test of safety and possible benefit, ended during a study of deep belly fat in people living with HIV. Public records don't give the reason the long-acting program ended.
When an online plan for the compound gives a number, ask where it came from. Most other numbers didn't come from a controlled human trial. Repeating an amount does not make it safe. The study record is not advice for you.